|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-6-27
|
|
pubmed:abstractText |
A comparative evaluation of the Abbott AxSYM and DPC Immulite random-access analyzers was performed using 497 prospectively collected serum samples. These samples were sent to the laboratory for routine antenatal screening for hepatitis B surface antigen and immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii and rubella virus. The overall agreement between the two assay systems ranged from 97.4 to 100%. After discrepancy analysis, the outcome in terms of sensitivity and specificity varied from 98.2 to 100% for all but one of the assays tested. The AxSYM rubella virus IgG assay tended to report protective or indeterminate antibody levels in 1% of the samples. This shortcoming might be overcome by raising the cutoff of the microparticle enzyme immunoassay system.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-10082699,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-10535651,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-2458201,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-2681638,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-3326123,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-3946544,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-4158018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-4551395,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-7814536,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-9823527,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11427427-9915044
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1071-412X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
785-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11427427-Animals,
pubmed-meshheading:11427427-Antibodies, Protozoan,
pubmed-meshheading:11427427-Antibodies, Viral,
pubmed-meshheading:11427427-Female,
pubmed-meshheading:11427427-Hepatitis B,
pubmed-meshheading:11427427-Hepatitis B Surface Antigens,
pubmed-meshheading:11427427-Hepatitis B virus,
pubmed-meshheading:11427427-Humans,
pubmed-meshheading:11427427-Immunoassay,
pubmed-meshheading:11427427-Pregnancy,
pubmed-meshheading:11427427-Prenatal Diagnosis,
pubmed-meshheading:11427427-Prospective Studies,
pubmed-meshheading:11427427-Reagent Kits, Diagnostic,
pubmed-meshheading:11427427-Rubella,
pubmed-meshheading:11427427-Toxoplasma,
pubmed-meshheading:11427427-Toxoplasmosis
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.
|
|
pubmed:affiliation |
Laboratory for Medical Microbiology, Diakonessen Hospital, Utrecht, The Netherlands. Rdiepersloot@diakhuis.nl
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|
